Literature DB >> 23638265

Tuberculosis drug resistance and outcomes among tuberculosis inpatients in Lilongwe, Malawi.

Charles Vorkas1, Dumbani Kayira, Charles van der Horst, Irving Hoffman, Mina Hosseinipour, Creto Kanyemba, Nelson Nguluwe, Tarsizio Chikaonda, Maximina Kalikhoka, Doreen Kalaundi, Dan Namarika, Peter Gilligan, Robert Krysiak.   

Abstract

UNLABELLED: SETTING/
OBJECTIVE: We evaluated clinical characteristics, yield of solid vs. liquid culture, polymerase chain reaction (PCR)-based drug-resistance profiles, and clinical outcomes of tuberculosis (TB) inpatients in Lilongwe, Malawi.
DESIGN: We enrolled adult patients admitted to the Bwaila TB Ward from Jan-Aug/2010. Evaluations included questionnaires, clinical exam, chest radiograph, HIV status, CD4 lymphocyte count, plasma HIVRNA and sputum analysis including Auramine-O stain, Lowenstein-Jensen (LJ) and Mycobacterial Growth Indicator Tube (MGIT) culture, and susceptibility testing using the HAIN GenoType® MTBDRplus.
RESULTS: Eighty-eight patients were enrolled (88% re-treatment, 42% smear positive, 93% pulmonary TB, 74% HIV co-infected). At baseline, 44/88 (50%) MGIT and 28 (32%) LJ cultures were positive with a mean time to positivity of 12.1 (Range 1-42) and 21.5 (Range 7-58) days, respectively. Four percent (3/77) of retreatment patients or 8% of the 38 MGIT+ PCR-confirmed retreatment cases had multi-drug resistant tuberculosis (MDR TB). One MDR TB patient was smear negative and only one MDR patient was identified with LJ. Lower mean hemoglobin at admission was associated with mortality (10.5 vs. 7.5; p<0.01; CI 101 9.8-11.0).
CONCLUSIONS: The MDR TB burden among the retreatment population in Lilongwe, Malawi is similar to regional estimates by the WHO (7.7% 95% CI 0-18.1). MDR TB patients are not routinely identified with sputum smear or LJ, suggesting more efficient technology should be adopted.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23638265      PMCID: PMC3588213     

Source DB:  PubMed          Journal:  Malawi Med J        ISSN: 1995-7262            Impact factor:   0.875


  13 in total

1.  Comparison of the automated nonradiometric Bactec MGIT 960 system with Löwenstein-Jensen, Coletsos, and Middlebrook 7H11 solid media for recovery of mycobacteria.

Authors:  P Idigoras; X Beristain; A Iturzaeta; D Vicente; E Pérez-Trallero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-05       Impact factor: 3.267

2.  Comparison of the Automated Mycobacteria Growth Indicator Tube System (BACTEC 960/MGIT) with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens.

Authors:  Dongsi Lu; Bobbi Heeren; W Michael Dunne
Journal:  Am J Clin Pathol       Date:  2002-10       Impact factor: 2.493

3.  GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis.

Authors:  D I Ling; A A Zwerling; M Pai
Journal:  Eur Respir J       Date:  2008-07-09       Impact factor: 16.671

4.  A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex.

Authors:  F M Gordin; P M Sullam; S D Shafran; D L Cohn; B Wynne; L Paxton; K Perry; C R Horsburgh
Journal:  Clin Infect Dis       Date:  1999-05       Impact factor: 9.079

5.  Delays in diagnosis and treatment of smear-positive tuberculosis and the incidence of tuberculosis in hospital nurses in Blantyre, Malawi.

Authors:  A D Harries; A Kamenya; D Namarika; I W Msolomba; F M Salaniponi; D S Nyangulu; P Nunn
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Jan-Feb       Impact factor: 2.184

6.  Evaluation of the MTBDRsl test for detection of second-line-drug resistance in Mycobacterium tuberculosis.

Authors:  Vo Sy Kiet; Nguyen Thi Ngoc Lan; Duong Duy An; Nguyen Huy Dung; Dai Viet Hoa; Nguyen van Vinh Chau; Nguyen Tran Chinh; Jeremy Farrar; Maxine Caws
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

7.  Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens.

Authors:  H P Chien; M C Yu; M H Wu; T P Lin; K T Luh
Journal:  Int J Tuberc Lung Dis       Date:  2000-09       Impact factor: 2.373

8.  Rapid molecular detection of tuberculosis and rifampin resistance.

Authors:  Catharina C Boehme; Pamela Nabeta; Doris Hillemann; Mark P Nicol; Shubhada Shenai; Fiorella Krapp; Jenny Allen; Rasim Tahirli; Robert Blakemore; Roxana Rustomjee; Ana Milovic; Martin Jones; Sean M O'Brien; David H Persing; Sabine Ruesch-Gerdes; Eduardo Gotuzzo; Camilla Rodrigues; David Alland; Mark D Perkins
Journal:  N Engl J Med       Date:  2010-09-01       Impact factor: 91.245

9.  Costs and cost-effectiveness of tuberculosis cultures using solid and liquid media in a developing country.

Authors:  D H Mueller; L Mwenge; M Muyoyeta; M W Muvwimi; R Tembwe; R McNerney; P Godfrey-Faussett; H M Ayles
Journal:  Int J Tuberc Lung Dis       Date:  2008-10       Impact factor: 2.373

10.  Identification of nontuberculous mycobacteria in clinical samples using molecular methods: a 3-year study.

Authors:  I Couto; D Machado; M Viveiros; L Rodrigues; L Amaral
Journal:  Clin Microbiol Infect       Date:  2009-10-14       Impact factor: 8.067

View more
  5 in total

1.  Prevalence of drug resistant TB among outpatients at an HIV/TB clinic in Lilongwe, Malawi.

Authors:  Brian Barnett; Runa H Gokhale; Robert Krysiak; Creto Kanyemba; Tarsizio Chikaonda; Mphatso Bokosi; Cornelius Mukuzunga; Friday Saidi; Sam Phiri; Irving F Hoffman; Mina C Hosseinipour
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-12       Impact factor: 2.184

2.  Map the gap: missing children with drug-resistant tuberculosis.

Authors:  C M Yuen; C A Rodriguez; S Keshavjee; M C Becerra
Journal:  Public Health Action       Date:  2015-03-21

3.  Liquid vs Solid Culture Medium to Evaluate Proportion and Time to Change in Management of Suspects of Tuberculosis-A Pragmatic Randomized Trial in Secondary and Tertiary Health Care Units in Brazil.

Authors:  Adriana da Silva Rezende Moreira; Gisele Huf; Maria Armanda Monteiro da Silva Vieira; Paulo Albuquerque da Costa; Fábio Aguiar; Anna Grazia Marsico; Leila de Souza Fonseca; Mônica Ricks; Martha Maria Oliveira; Anne Detjen; Paula Isono Fujiwara; Stephen Bertel Squire; Afranio Lineu Kritski
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

4.  Mycobacterium tuberculosis mixed infections and drug resistance in sub-Saharan Africa: a systematic review.

Authors:  Lisa Nkatha Micheni; Serawit Deyno; Joel Bazira
Journal:  Afr Health Sci       Date:  2022-03       Impact factor: 1.108

5.  Detection of Mycobacterium tuberculosis multiple strains in sputum samples from patients with pulmonary tuberculosis in south western Uganda using MIRU-VNTR.

Authors:  Lisa Nkatha Micheni; Kennedy Kassaza; Hellen Kinyi; Ibrahim Ntulume; Joel Bazira
Journal:  Sci Rep       Date:  2022-01-31       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.